Literature DB >> 6313733

Loss of adrenocortical suppression after acute brain injury: role of increased intracranial pressure and brain stem function.

J Feibel, M Kelly, L Lee, P Woolf.   

Abstract

The function of the pituitary-adrenal axis was studied in 23 acutely brain-injured, comatose patients (14 head trauma and 9 intracranial hemorrhage), who were treated with dexamethasone (16-64 mg/daily). Patients with normal intracranial pressure (ICP) and normal brain stem function (group 1) had decreased plasma cortisol levels (less than or equal to 5 micrograms/dl) within 36 h (mean +/- SEM, 2.4 +/- 0.3 microgram/dl; t 1/2, 18 h). In contrast, patients with elevated ICP (i.e. greater than 20 mm Hg; midline shift, or compressed ventricles) and normal brain stem function (group 2) had persistently elevated cortisol concentrations (15.4 +/- 2.6 micrograms/dl; P less than 0.001). Superimposition of brain stem dysfunction resulted in generally low cortisol levels regardless of the presence (group 4; 3.9 +/- 1.0 microgram/dl; P less than 0.001 compared to group 2) or absence (group 3; 2.1 +/- 0.5 microgram/dl) of elevated ICP. Plasma ACTH levels in 31 samples obtained before or during dexamethasone therapy in 14 patients irrespective of group were not elevated (45.6 +/- 12.5 pg/ml); there was no correlation between plasma ACTH and cortisol levels. Despite elevated cortisol values in group 2, ACTH levels were low (22.4 +/- 10.1 pg/ml). It is concluded that elevated ICP in the presence of normal brain stem function is a potent stimulus for adrenocortical activation which is not associated with elevated ACTH levels, and that the brain stem is involved in this response.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6313733     DOI: 10.1210/jcem-57-6-1245

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Physiology and metabolism in closed head injury.

Authors:  C S Deutschman
Journal:  World J Surg       Date:  1987-04       Impact factor: 3.352

Review 2.  Hypothalamic-pituitary dysfunction in critically ill patients with traumatic and nontraumatic brain injury.

Authors:  Ioanna Dimopoulou; Stylianos Tsagarakis
Journal:  Intensive Care Med       Date:  2005-06-15       Impact factor: 17.440

3.  Function tests on the neuroendocrine hypothalamo-pituitary system following acute midbrain syndrome, with special reference to computertomographical and magnetic resonance imaging results.

Authors:  J Lenzen; G Hildebrand; A Laun; H Stracke; H Müller; H Schatz
Journal:  Neurosurg Rev       Date:  1993       Impact factor: 3.042

4.  Endocrine abnormalities in critical care patients with moderate-to-severe head trauma: incidence, pattern and predisposing factors.

Authors:  Ioanna Dimopoulou; Stylianos Tsagarakis; Maria Theodorakopoulou; Evangelia Douka; Maria Zervou; Andreas T Kouyialis; Nikolaos Thalassinos; Charis Roussos
Journal:  Intensive Care Med       Date:  2004-04-07       Impact factor: 17.440

Review 5.  Glucocorticoid therapy and ocular hypertension.

Authors:  Adnan Dibas; Thomas Yorio
Journal:  Eur J Pharmacol       Date:  2016-07-05       Impact factor: 4.432

Review 6.  Pituitary and/or hypothalamic dysfunction following moderate to severe traumatic brain injury: Current perspectives.

Authors:  Zeeshan Javed; Unaiza Qamar; Thozhukat Sathyapalan
Journal:  Indian J Endocrinol Metab       Date:  2015 Nov-Dec

7.  Endocrine dysfunction following traumatic brain injury: a 5-year follow-up nationwide-based study.

Authors:  Wei-Hsun Yang; Pau-Chung Chen; Ting-Chung Wang; Ting-Yu Kuo; Chun-Yu Cheng; Yao-Hsu Yang
Journal:  Sci Rep       Date:  2016-09-09       Impact factor: 4.379

8.  Pituitary dysfunction in traumatic brain injury: Is evaluation in the acute phase worthwhile?

Authors:  Pradip P Dalwadi; Nikhil M Bhagwat; Parimal S Tayde; Ameya S Joshi; Premlata K Varthakavi
Journal:  Indian J Endocrinol Metab       Date:  2017 Jan-Feb
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.